April 29th 2024
Approval of Libervant marks the first orally administered rescue medication for this age group to be cleared by the FDA for epilepsy.
Crafting Culturally Sensitive Messages to Reach Diverse Audiences and Improve Patient Outcomes
April 25th 2024In this Pharmaceutical Executive video interview, Amanda Powers-Han, Chief Marketing Officer, Greater Than One, discusses how improved DE&I in healthcare marketing strategies can not only reach diverse audiences more effectively but address their specific healthcare needs